Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Burkov

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Terapevticheskii Arkhiv|April 1, 2016
[European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers]D S Bordin, O B Yanova, R A Abdulkhakov, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Terapevticheskii Arkhiv|April 1, 2016
[European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers]D S Bordin, O B Yanova, R A Abdulkhakov, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
Pageof 5